Christopher J H Porter (Christopher Jh Porter)

Scopus Author ID Loop profile ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2015-2023
Publications (10 Years): 35

Top Venues

Molecular pharmaceutics

Biomacromolecules

The Journal of biological chemistry

Nature nanotechnology

Monash University - Parkville Campus

University of Nottingham (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Monash University - Parkville Campus

Australia

Director :: Monash Institute of Pharmaceutical Sciences

Education History

University of Nottingham

United Kingdom

PHD :: Pharmacy

Publications

Alina D Lam, Ian K Styles, Danielle Senyschyn, Enyuan Cao, Abel Anshabo, Mohammad Abdallah, Reyaj Mikrani, Cameron J Nowell, Christopher J H Porter, Orlagh M Feeney, Natalie L Trevaskis
Intra-articular Injection of a B Cell Depletion Antibody Enhances Local Exposure to the Joint-Draining Lymph Node in Mice with Collagen-Induced Arthritis. Molecular pharmaceutics (2023)
Alexander J Martin, David M Shackleford, Susan A Charman, Kylie M Wagstaff, Christopher J H Porter, David A Jans
Increased In Vivo Exposure of N-(4-Hydroxyphenyl) Retinamide (4-HPR) to Achieve Plasma Concentrations Effective against Dengue Virus. Pharmaceutics 15 (7) (2023)
Sifei Han, Tim Quach, Luojuan Hu, Shea Fern Lim, Dan Zheng, Nathania J Leong, Garima Sharma, Daniel Bonner, Jamie S Simpson, Natalie L Trevaskis, Christopher J H Porter
Increasing Linker Chain Length and Intestinal Stability Enhances Lymphatic Transport and Lymph Node Exposure of Triglyceride Mimetic Prodrugs of a Model Immunomodulator Mycophenolic Acid. Molecular pharmaceutics (2023)
Orlagh M Feeney, Christopher J H Porter, Kara Lea Vine
Introducing the Molecular Pharmaceutics Special Issue on "Emerging Trends in Molecular Pharmaceutics across Australasia". Molecular pharmaceutics 20 (4) (2023)
Andrew Kerr, Erny Sagita, Edward D H Mansfield, Tri-Hung Nguyen, Orlagh M Feeney, Colin W Pouton, Christopher J H Porter, Joaquin Sanchis, Sebastien Perrier
Polymeric Nanotubes as Drug Delivery Vectors─Comparison of Covalently and Supramolecularly Assembled Constructs. Biomacromolecules 23 (6) (2022)
Daniel Hs Brundel, Orlagh M Feeney, Cameron J Nowell, Estelle J A Suys, Gracia Gracia, Lisa M Kaminskas, Michelle M McIntosh, David W Kang, Christopher J H Porter
Depolymerization of hyaluronan using PEGylated human recombinant hyaluronidase promotes nanoparticle tumor penetration. Nanomedicine (London, England) 16 (4) (2021)
Yusuke Tanaka, Tri-Hung Nguyen, Estelle J A Suys, Christopher J H Porter
Digestion of Lipid-Based Formulations Not Only Mediates Changes to Absorption of Poorly Soluble Drugs Due to Differences in Solubilization But Also Reflects Changes to Thermodynamic Activity and Permeability. Molecular pharmaceutics 18 (4) (2021)
Shiyao Li, Yi Ju, Jiajing Zhou, Ka Fung Noi, Andrew J Mitchell, Tian Zheng, Stephen J Kent, Christopher J H Porter, Frank Caruso
Quantitatively Tracking Bio-Nano Interactions of Metal-Phenolic Nanocapsules by Mass Cytometry. ACS applied materials & interfaces 13 (30) (2021)
Enyuan Cao, Matthew J Watt, Cameron J Nowell, Tim Quach, Jamie S Simpson, Vilena De Melo Ferreira, Sonya Agarwal, Hannah Chu, Anubhav Srivastava, Dovile Anderson, Gracia Gracia, Alina Lam, Gabriela Segal, Jiwon Hong, Luojuan Hu, Kian Liun Phang, Alistair B J Escott, John A Windsor, Anthony R J Phillips, Darren John Creek, Natasha L Harvey, Christopher J H Porter, Natalie L Trevaskis
Mesenteric lymphatic dysfunction promotes insulin resistance and represents a potential treatment target in obesity. Nature metabolism 3 (9) (2021)
Yusuke Tanaka, Erin Tay, Tri-Hung Nguyen, Christopher J H Porter
Quantifying In Vivo Luminal Drug Solubilization -Supersaturation-Precipitation Profiles to Explain the Performance of Lipid Based Formulations. Pharmaceutical research 37 (3) (2020)
Christopher J H Porter, Natalie L Trevaskis
Targeting immune cells within lymph nodes. Nature nanotechnology 15 (6) (2020)
Gracia Gracia, Enyuan Cao, Orlagh M Feeney, Angus P R Johnston, Christopher J H Porter, Natalie L Trevaskis
High-Density Lipoprotein Composition Influences Lymphatic Transport after Subcutaneous Administration. Molecular pharmaceutics 17 (8) (2020)
Given Lee, Sifei Han, Iasmin Inocencio, Enyuan Cao, Jiwon Hong, Anthony R J Phillips, John A Windsor, Christopher J H Porter, Natalie L Trevaskis
Lymphatic Uptake of Liposomes after Intraperitoneal Administration Primarily Occurs via the Diaphragmatic Lymphatics and is Dependent on Liposome Surface Properties. Molecular pharmaceutics 16 (12) (2019)
Ken W Yong, Daniel Yuen, Moore Z Chen, Christopher J H Porter, Angus P R Johnston
Pointing in the Right Direction: Controlling the Orientation of Proteins on Nanoparticles Improves Targeting Efficiency. Nano letters 19 (3) (2019)
Yutian Ma, Christina Cortez-Jugo, Jianhua Li, Zhixing Lin, Rachael T Richardson, Yiyuan Han, Jiajing Zhou, Mattias Björnmalm, Orlagh M Feeney, Qi-Zhi Zhong, Christopher J H Porter, Andrew K Wise, Frank Caruso
Engineering Biocoatings To Prolong Drug Release from Supraparticles. Biomacromolecules 20 (9) (2019)
Matthew Faria, Mattias Björnmalm, Kristofer J Thurecht, Stephen J Kent, Robert G Parton, Maria Kavallaris, Angus P R Johnston, J Justin Gooding, Simon R Corrie, Ben J Boyd, Pall Thordarson, Andrew K Whittaker, Molly M Stevens, Clive A Prestidge, Christopher J H Porter, Wolfgang J Parak, Thomas P Davis, Edmund J Crampin, Frank Caruso
Minimum information reporting in bio-nano experimental literature. Nature nanotechnology 13 (9) (2018)
Dane D Jensen, TinaMarie Lieu, Michelle L Halls, Nicholas A Veldhuis, Wendy L Imlach, Quynh N Mai, Daniel P Poole, Tim Quach, Luigi Aurelio, Joshua W Conner, Carmen Klein Herenbrink, Nicholas Barlow, Jamie S Simpson, Martin J Scanlon, Bimbil Graham, Adam McCluskey, Phillip J Robinson, Virginie Escriou, Romina Nassini, Serena Materazzi, Pierangelo Geppetti, Gareth A Hicks, Macdonald J Christie, Christopher J H Porter, Meritxell Canals, Nigel W Bunnett
Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief. Science translational medicine 9 (392) (2018)
Rahul Patil, Biswaranjan Mohanty, Bonan Liu, Indu R Chandrashekaran, Stephen J Headey, Martin L Williams, Craig S Clements, Olga Ilyichova, Bradley C Doak, Patrick Genissel, Richard J Weaver, Laurent Vuillard, Michelle L Halls, Christopher J H Porter, Martin J Scanlon
A ligand-induced structural change in fatty acid-binding protein 1 is associated with potentiation of peroxisome proliferator-activated receptor α agonists. The Journal of biological chemistry 294 (10) (2018)
Dharmini Mehta, Nathania Leong, Victoria M McLeod, Brian D Kelly, Rashmi Pathak, David J Owen, Christopher J H Porter, Lisa M Kaminskas
Reducing Dendrimer Generation and PEG Chain Length Increases Drug Release and Promotes Anticancer Activity of PEGylated Polylysine Dendrimers Conjugated with Doxorubicin via a Cathepsin-Cleavable Peptide Linker. Molecular pharmaceutics 15 (10) (2018)
Estelle J A Suys, David K Chalmers, Colin W Pouton, Christopher J H Porter
Polymeric Precipitation Inhibitors Promote Fenofibrate Supersaturation and Enhance Drug Absorption from a Type IV Lipid-Based Formulation. Molecular pharmaceutics 15 (6) (2018)
Nestor N Jimenez-Vargas, Luke A Pattison, Peishen Zhao, TinaMarie Lieu, Rocco Latorre, Dane D Jensen, Joel Castro, Luigi Aurelio, Giang T Le, Bernard Flynn, Carmen Klein Herenbrink, Holly R Yeatman, Laura Edgington-Mitchell, Christopher J H Porter, Michelle L Halls, Meritxell Canals, Nicholas A Veldhuis, Daniel P Poole, Peter McLean, Gareth A Hicks, Nicole Scheff, Elyssa Chen, Aditi Bhattacharya, Brian L Schmidt, Stuart M Brierley, Stephen J Vanner, Nigel W Bunnett
Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome. Proceedings of the National Academy of Sciences of the United States of America 115 (31) (2018)
Linda C Alskär, Janneke Keemink, Jenny Johannesson, Christopher J H Porter, Christel A S Bergström
Impact of Drug Physicochemical Properties on Lipolysis-Triggered Drug Supersaturation and Precipitation from Lipid-Based Formulations. Molecular pharmaceutics 15 (10) (2018)
Yutian Ma, Mattias Björnmalm, Andrew K Wise, Christina Cortez-Jugo, Eve Revalor, Yi Ju, Orlagh M Feeney, Rachael T Richardson, Eric Hanssen, Robert K Shepherd, Christopher J H Porter, Frank Caruso
Gel-Mediated Electrospray Assembly of Silica Supraparticles for Sustained Drug Delivery. ACS applied materials & interfaces 10 (37) (2018)
Hywel D Williams, Leigh Ford, Sifei Han, Kristian J Tangso, Shea Lim, David M Shackleford, David T Vodak, Hassan Benameur, Colin W Pouton, Peter J Scammells, Christopher J H Porter
Enhancing the Oral Absorption of Kinase Inhibitors Using Lipophilic Salts and Lipid-Based Formulations. Molecular pharmaceutics 15 (12) (2018)
Estelle J A Suys, Dallas B Warren, Christopher J H Porter, Hassan Benameur, Colin W Pouton, David K Chalmers
Computational Models of the Intestinal Environment. 3. The Impact of Cholesterol Content and pH on Mixed Micelle Colloids. Molecular pharmaceutics 14 (11) (2017)
Woldeamanuel A Birru, Dallas B Warren, Sifei Han, Hassan Benameur, Christopher J H Porter, Colin W Pouton, David K Chalmers
Computational Models of the Gastrointestinal Environment. 2. Phase Behavior and Drug Solubilization Capacity of a Type I Lipid-Based Drug Formulation after Digestion. Molecular pharmaceutics 14 (3) (2017)
Yijun Pan, Jennifer L Short, Kwok H C Choy, Annie X Zeng, Philip J Marriott, Yuji Owada, Martin J Scanlon, Christopher J H Porter, Joseph A Nicolazzo
Fatty Acid-Binding Protein 5 at the Blood-Brain Barrier Regulates Endogenous Brain Docosahexaenoic Acid Levels and Cognitive Function. The Journal of neuroscience : the official journal of the Society for Neuroscience 36 (46) (2017)
Rebecca E Yarwood, Wendy L Imlach, TinaMarie Lieu, Nicholas A Veldhuis, Dane D Jensen, Carmen Klein Herenbrink, Luigi Aurelio, Zhijian Cai, MacDonald J Christie, Daniel P Poole, Christopher J H Porter, Peter McLean, Gareth A Hicks, Pierangelo Geppetti, Michelle L Halls, Meritxell Canals, Nigel W Bunnett
Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission. Proceedings of the National Academy of Sciences of the United States of America 114 (46) (2017)
Eunice E To, Ross Vlahos, Raymond Luong, Michelle L Halls, Patrick C Reading, Paul T King, Christopher Chan, Grant R Drummond, Christopher G Sobey, Brad R S Broughton, Malcolm R Starkey, Renee van der Sluis, Sharon R Lewin, Steven Bozinovski, Luke A J O'Neill, Tim Quach, Christopher J H Porter, Doug A Brooks, John J O'Leary, Stavros Selemidis
Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy. Nature communications 8 (1) (2017)
Claire L McEvoy, Natalie L Trevaskis, Orlagh M Feeney, Glenn A Edwards, Michael E Perlman, Catherine M Ambler, Christopher J H Porter
Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623. Molecular pharmaceutics 14 (12) (2017)
Linda J Chan, Orlagh M Feeney, Nathania J Leong, Victoria M McLeod, Christopher J H Porter, Charlotte C Williams, Lisa M Kaminskas
An Evaluation of Optimal PEGylation Strategies for Maximizing the Lymphatic Exposure and Antiviral Activity of Interferon after Subcutaneous Administration. Biomacromolecules 18 (9) (2017)
Matthew F Crum, Natalie L Trevaskis, Colin W Pouton, Christopher J H Porter
Transient Supersaturation Supports Drug Absorption from Lipid-Based Formulations for Short Periods of Time, but Ongoing Solubilization Is Required for Longer Absorption Periods. Molecular pharmaceutics 14 (2) (2017)
Woldeamanuel A Birru, Dallas B Warren, Stephen J Headey, Hassan Benameur, Christopher J H Porter, Colin W Pouton, David K Chalmers
Computational Models of the Gastrointestinal Environment. 1. The Effect of Digestion on the Phase Behavior of Intestinal Fluids. Molecular pharmaceutics 14 (3) (2017)
Yasemin Sahbaz, Tri-Hung Nguyen, Leigh Ford, Claire L McEvoy, Hywel D Williams, Peter J Scammells, Christopher J H Porter
Ionic Liquid Forms of Weakly Acidic Drugs in Oral Lipid Formulations: Preparation, Characterization, in Vitro Digestion, and in Vivo Absorption Studies. Molecular pharmaceutics 14 (11) (2017)
Luojuan Hu, Tim Quach, Sifei Han, Shea F Lim, Preeti Yadav, Danielle Senyschyn, Natalie L Trevaskis, Jamie S Simpson, Christopher J H Porter
Glyceride-Mimetic Prodrugs Incorporating Self-Immolative Spacers Promote Lymphatic Transport, Avoid First-Pass Metabolism, and Enhance Oral Bioavailability. Angewandte Chemie (International ed. in English) 55 (44) (2016)
Maria L R Hughes, Bonan Liu, Michelle L Halls, Kylie M Wagstaff, Rahul Patil, Tony Velkov, David A Jans, Nigel W Bunnett, Martin J Scanlon, Christopher J H Porter
Fatty Acid-binding Proteins 1 and 2 Differentially Modulate the Activation of Peroxisome Proliferator-activated Receptor α in a Ligand-selective Manner. The Journal of biological chemistry 290 (22) (2015)

Christopher J H Porter.css-eqlu8i{font-size:small;padding-left:4px;} (Christopher Jh Porter)

Publication Activity (10 Years)

Top Topics

Top Venues

Christopher J H Porter (Christopher Jh Porter)